GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 389 participants.

Also called NCT07228117

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 389 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07228117
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, New Zealand (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07228117. Randomized; no masking; primary purpose other. Start 2026-02-02 (actual); primary completion 2027-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Condition
Type 1 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
MiniMed™ NMX8-AID System with DS5™/Simplera Sync™
Lead sponsor
Medtronic MiniMed, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07228117
Content hash
be618391eb44063526d66817e3c4107f2a0d1748511e8d98f73cbe53375eb54b